Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 12, 1996, Pages 2765-2768

  Roord, John J ^a   Wolf, Bart H M ^b   Goossens, Margot M H T ^c   Kimpen, Jan L L ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c Kendle/U gene Research   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN;

ADOLESCENT; ANTIBACTERIAL ACTIVITY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENCY; DRUG SAFETY; DRUG STABILITY; FEMALE; FLATULENCE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN BINDING; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0029847106     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.12.2765     Document Type: Article

References (11)

1. Ball, P. 1991. The future role and importance of macrolides. J. Hosp. Infect. 19:SA47-SA59.
2. Bartlett, J. G., and L. M. Mundy. 1995. Community-acquired pneumonia. N. Engl. J. Med. 333:1618-1624.
3. Felstead, S. J., R. Daniel, and European Azithromycin Study Group. 1991. Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. J. Int. Med. Res. 19:363-372.
4. Hopkins, S. 1991. Clinical toleration and safety of azithromycin. Am. J. Med. 91(Suppl. 3A):40-45.
5. McLinn, S. 1995. Double blind and open label studies of azithromycin in the management of acute otitis media in children: a review. Pediatr. Infect. Dis. J. 14:S62-S66.
6. Nahata, M. C., K. I. Koranyi, S. D. Gadgil, D. M. Hilligoss, H. G. Fouda, and M. J. Gardner. 1993. Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple closes of suspension. Antimicrob. Agents Chemother. 37:314-316.
7. Neu, H. C. 1991. Clinical microbiology of azithromycin. Am. J. Med. 91 (Suppl. 3A):12-18.
8. Rodriguez-Solares, A., F. Perez-Gutierrez, J. Prosperi, E. Milgram, and A. Martin. 1993. A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections. J. Antimicrob. Chemother. 31(Suppl. E):103-109.
9. Schentag, J. J., and C. H. Ballow. 1991. Tissue-directed pharmacokinetics. Am. J. Med. 91(Suppl. 3A):5-11.
10. Treadway, G., and D. Pontani. 1996. Paediatric safety of azithromycin: worldwide experience. J. Antimicrob. Chemother. 37(Suppl. C):143-149.
11. Weippl, G. 1993. Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis or tonsillitis caused by group A streptococci. J. Antimicrob. Chemother. 31(Suppl. E):95-101.